| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973289 | The Journal of Heart and Lung Transplantation | 2007 | 8 Pages |
Abstract
Preliminary data suggest that CNI-free immunosuppression using everolimus is safe, with excellent efficacy in maintenance heart transplant recipients. Arterial hypertension and renal function improved significantly. CNI-induced side effects such as tremor, peripheral edema, hirsutism, and gingival hyperplasia markedly improved in most patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Markus MD, PhD, Elisa Teerling, Christian MD, PhD, Hans MD, Barbara MD, PhD, Christoph MD, Thomas MD, PhD, Frank MD, PhD, Christof MD, PhD, Joerg MD,